
William P. Neuder
Examiner (ID: 10341)
| Most Active Art Unit | 3672 |
| Art Unit(s) | 3672, 2899, 3625, 3642, 3506 |
| Total Applications | 4583 |
| Issued Applications | 4090 |
| Pending Applications | 166 |
| Abandoned Applications | 332 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16539262
[patent_doc_number] => 20200405675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/016577
[patent_app_country] => US
[patent_app_date] => 2020-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15128
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17016577
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/016577 | Stable pharmaceutical composition and methods of using same | Sep 9, 2020 | Issued |
Array
(
[id] => 16726441
[patent_doc_number] => 20210093588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => Bis-Choline Tetrathiomolybdate for Treating Wilson Disease
[patent_app_type] => utility
[patent_app_number] => 16/997928
[patent_app_country] => US
[patent_app_date] => 2020-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26654
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16997928
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/997928 | Bis-choline tetrathiomolybdate for treating Wilson Disease | Aug 18, 2020 | Issued |
Array
(
[id] => 17798996
[patent_doc_number] => 11413262
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-16
[patent_title] => Pharmaceutical compositions comprising levodopa, a dopamine decarboxylase inhibitor and a COMT inhibitor and method of administration thereof
[patent_app_type] => utility
[patent_app_number] => 16/992824
[patent_app_country] => US
[patent_app_date] => 2020-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 18476
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16992824
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/992824 | Pharmaceutical compositions comprising levodopa, a dopamine decarboxylase inhibitor and a COMT inhibitor and method of administration thereof | Aug 12, 2020 | Issued |
Array
(
[id] => 18732511
[patent_doc_number] => 11801229
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-31
[patent_title] => Molecular entrapment via homopolymer self-assembly
[patent_app_type] => utility
[patent_app_number] => 16/942228
[patent_app_country] => US
[patent_app_date] => 2020-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 37
[patent_no_of_words] => 17654
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16942228
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/942228 | Molecular entrapment via homopolymer self-assembly | Jul 28, 2020 | Issued |
Array
(
[id] => 16548495
[patent_doc_number] => 10881632
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-05
[patent_title] => Stable pharmaceutical composition and methods of using same
[patent_app_type] => utility
[patent_app_number] => 16/894567
[patent_app_country] => US
[patent_app_date] => 2020-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 15129
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16894567
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/894567 | Stable pharmaceutical composition and methods of using same | Jun 4, 2020 | Issued |
Array
(
[id] => 18383343
[patent_doc_number] => 11654107
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-23
[patent_title] => Animal treat composition for delivery of oral medication
[patent_app_type] => utility
[patent_app_number] => 16/892220
[patent_app_country] => US
[patent_app_date] => 2020-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 15628
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16892220
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/892220 | Animal treat composition for delivery of oral medication | Jun 2, 2020 | Issued |
Array
(
[id] => 17936984
[patent_doc_number] => 11471416
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-18
[patent_title] => Extended release pharmaceutical formulation and methods of treatment
[patent_app_type] => utility
[patent_app_number] => 16/890222
[patent_app_country] => US
[patent_app_date] => 2020-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 28
[patent_no_of_words] => 20703
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16890222
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/890222 | Extended release pharmaceutical formulation and methods of treatment | Jun 1, 2020 | Issued |
Array
(
[id] => 17726495
[patent_doc_number] => 11382860
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-12
[patent_title] => Optimized pharmaceutical formulation for the treatment of inflammatory conditions of the esophagus
[patent_app_type] => utility
[patent_app_number] => 16/875573
[patent_app_country] => US
[patent_app_date] => 2020-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5534
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16875573
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/875573 | Optimized pharmaceutical formulation for the treatment of inflammatory conditions of the esophagus | May 14, 2020 | Issued |
Array
(
[id] => 18707592
[patent_doc_number] => 20230330169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => PHARMACEUTICAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/788198
[patent_app_country] => US
[patent_app_date] => 2020-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9197
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17788198
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/788198 | PHARMACEUTICAL COMPOSITIONS | Apr 23, 2020 | Pending |
Array
(
[id] => 17140034
[patent_doc_number] => 20210308045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => System and Method of Administering a Freezable Cough Drop to a User
[patent_app_type] => utility
[patent_app_number] => 16/842578
[patent_app_country] => US
[patent_app_date] => 2020-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2337
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16842578
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/842578 | System and method of administering a freezable cough drop to a user | Apr 6, 2020 | Issued |
Array
(
[id] => 16189196
[patent_doc_number] => 20200230045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => COMPOSITION COMPRISING NIACINAMIDE AND PICOLINAMIDE
[patent_app_type] => utility
[patent_app_number] => 16/822183
[patent_app_country] => US
[patent_app_date] => 2020-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4257
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16822183
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/822183 | Composition comprising niacinamide and picolinamide | Mar 17, 2020 | Issued |
Array
(
[id] => 16153493
[patent_doc_number] => 20200214979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => ORALLY ADMINISTERED CORTICOSTEROID COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/821464
[patent_app_country] => US
[patent_app_date] => 2020-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8711
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16821464
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/821464 | Orally administered corticosteroid compositions | Mar 16, 2020 | Issued |
Array
(
[id] => 17874302
[patent_doc_number] => 11446293
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-20
[patent_title] => Extended release, abuse deterrent dosage forms
[patent_app_type] => utility
[patent_app_number] => 16/818528
[patent_app_country] => US
[patent_app_date] => 2020-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10423
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16818528
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/818528 | Extended release, abuse deterrent dosage forms | Mar 12, 2020 | Issued |
Array
(
[id] => 19535607
[patent_doc_number] => 12128140
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-29
[patent_title] => Extended release pharmaceutical formulation
[patent_app_type] => utility
[patent_app_number] => 17/442239
[patent_app_country] => US
[patent_app_date] => 2020-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 25
[patent_no_of_words] => 22901
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 1087
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17442239
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/442239 | Extended release pharmaceutical formulation | Mar 4, 2020 | Issued |
Array
(
[id] => 16072915
[patent_doc_number] => 20200190444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => CLEANING COMPOSITION, METHOD OF MAKING AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/800596
[patent_app_country] => US
[patent_app_date] => 2020-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11300
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16800596
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/800596 | Cleaning composition, method of making and use thereof | Feb 24, 2020 | Issued |
Array
(
[id] => 16420472
[patent_doc_number] => 20200345670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => METHODS OF TREATMENT USING SUSTAINED RELEASE SOTALOL FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/791835
[patent_app_country] => US
[patent_app_date] => 2020-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10967
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16791835
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/791835 | METHODS OF TREATMENT USING SUSTAINED RELEASE SOTALOL FORMULATIONS | Feb 13, 2020 | Abandoned |
Array
(
[id] => 17193315
[patent_doc_number] => 11162058
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-02
[patent_title] => Liquid loading composition, method of making and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/790026
[patent_app_country] => US
[patent_app_date] => 2020-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12489
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16790026
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/790026 | Liquid loading composition, method of making and use thereof | Feb 12, 2020 | Issued |
Array
(
[id] => 15990417
[patent_doc_number] => 20200171079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => NITRIC OXIDE TOPICAL APPLICATION APPARATUS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 16/787357
[patent_app_country] => US
[patent_app_date] => 2020-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6031
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16787357
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/787357 | Nitric oxide topical application apparatus and methods | Feb 10, 2020 | Issued |
Array
(
[id] => 16221389
[patent_doc_number] => 20200246505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => MICROFLUIDIC EXTRUSION
[patent_app_type] => utility
[patent_app_number] => 16/779196
[patent_app_country] => US
[patent_app_date] => 2020-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25229
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16779196
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/779196 | Microfluidic extrusion | Jan 30, 2020 | Issued |
Array
(
[id] => 15960353
[patent_doc_number] => 20200163928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => Taxane Particles and Their Use
[patent_app_type] => utility
[patent_app_number] => 16/776919
[patent_app_country] => US
[patent_app_date] => 2020-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13221
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16776919
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/776919 | Taxane particles and their use | Jan 29, 2020 | Issued |